This brand name is authorized in Estonia, Spain, France, Malta, Netherlands, Romania
The drug NATULAN contains one active pharmaceutical ingredient (API):
1
Procarbazine hydrochloride
UNII XH0NPH5ZX8 - PROCARBAZINE HYDROCHLORIDE
|
Procarbazine, a methylhydrazine derivative, is a cytostatic agent with weak MAO inhibitor properties. Its exact mode of action on tumour cells is unknown. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
L01XB01 | Procarbazine | L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01X Other antineoplastic agents → L01XB Methylhydrazines |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: EE | Ravimiamet | Identifier(s): 1106637 |
Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 42248 |
Country: FR | Base de données publique des médicaments | Identifier(s): 69245055 |
Country: MT | Medicines Authority | Identifier(s): AA153/02001, AA729/26301 |
Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 1899 |
Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W59766002 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.